Operating margin moved 112596 bp higher
Operating margin changed +112596 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating margin changed +112596 basis points from the comparable as-filed period.
Research & development changed -53.7% from the comparable as-filed period.
Gross margin changed +2376 basis points from the comparable as-filed period.
Revenue changed +199.3% from the comparable as-filed period.
Current assets changed +26.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed -18.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Cash & equivalents changed -16.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Current liabilities changed +38.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Shares outstanding changed +141.6% from the comparable as-filed period. The change ranks at the 62th percentile of 8 prior comparable changes.
Stock-based compensation changed +81.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating cash flow changed -14.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Working capital changed +19.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 3 consecutive comparable moves in the opposite direction.
Capex / revenue changed +1858 basis points from the comparable as-filed period.
Cost of revenue changed +85.1% from the comparable as-filed period.
Gross profit changed +387.7% from the comparable as-filed period.
Inventory / revenue changed +26313 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.